|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Change in fair value of warrant liabilities and forward purchase agreement | |
| Interest and dividends earned on marketable securities held in Trust Account | |
| Offering costs allocated to derivative warrant liabilities | |
| Offering costs on Founder Shares issued to related party | |
| General and administrative expenses paid by related party | |
| Amortization of prepaid expenses | |
| Changes in operating assets and liabilities | |
| Prepaid expenses | |
| Other assets | |
| Accounts payable | |
| Franchise tax payable | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Investment of cash into Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Repayment of Sponsor loan | |
| Working capital loan from related party | |
| Proceeds from Initial Public Offering, net of underwriters' fees | |
| Proceeds from Private Placement Warrants | |
| Payment of other offering costs | |
| Net cash provided by financing activities | |
| Net increase in cash | |
| Cash—beginning of period | |
| Cash—end of period | |
| Supplemental disclosure of noncash financing activities: | |
| Deferred underwriting fees payable | |
| Offering costs included in accrued expenses | |
| Offering costs paid through promissory note—related party | |
| Deferred offering costs in accrued offering costs and accounts payable at December 31, 2020 |
Loading...
